Table 2.
Clinical characteristics of 121 patients tested for functional LSC and leukemic progenitor content
| All patients | LPC+ | LPC− | LSC+ | LSC− | |
|---|---|---|---|---|---|
| n | 121 | 68 | 48 | 52 | 57 |
| Age | |||||
| Years, median (range) | 63 (21–94) | 63 (24–94) | 63 (21–89) | 64 (24–89) | 59 (21–94) |
| Gender | |||||
| Female (%) | 43 | 40 | 46 | 44 | 42 |
| Blasts | |||||
| % median (range) | 86.3 (29.8–97.7) | 85.7 (29.8–97.7) | 87.0 (55–97.2) | 89.1 (34–97.7) | 82.3 (29.8–97.6) |
| ELNa | |||||
| Favorable, n (%) | 17 (22) | 9 (19) | 8 (30) | 7 (23) | 9 (23) |
| Intermediate, n (%) | 32 (42) | 17 (35) | 13 (48) | 11 (37) | 16 (41) |
| Adverse, n (%) | 28 (36) | 22 (46) | 6 (22) | 12 (40) | 14 (36) |
a
Information unavailable for one or more patients.